Case File
efta-efta01461523DOJ Data Set 10CorrespondenceEFTA Document EFTA01461523
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01461523
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
As of 4/2/14 3:27 pm
Description
Trade Date
Quantity
Current Price
Unit Cost
Market Value
Current Total Cost
Unrealized G/L
SANGAMO BIOSCIENCES
5/28/2013
50,000.00
$
17.51 $
8.44
$
875,500.00
422,214.00 $
453,286.00
BIOGEN
2/14/2012
2,095.00
$
308.71 $
119.55
$
646,747.45
250,454.95 $
396,292.50
FOUNDATION MEDICINE
1/13/2014
25,000.00
$
31.62
$
27.51
$
790,500.00
687,663.50 $
102,836.50
GILEAD SCIENCES INC
Multiple
8,100.00
$
73.79
$
79.41
$
597,699.00
643,204.00
$
(45,505.00)
Total Biotech
$
3,043,139.83
$
2,294,533.85
$
906,910.00
ARIAD PHARMACEUTICALS
Multiple
16,535.00
$
8.03
$
17.60
$
132,693.38
290,997.40 $
(158,304.03)
CONFIDENTIAL - PURSUANT TO FED. R. CRIM. P. 6(e)
CONFIDENTIAL
DB-SDNY-0 123633
SDNY_GM_00269817
EFTA01461523
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.